NCNorman H. L. Chiu

Norman H. L. Chiu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Norman H. L. Chiu has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Signs and Symptoms Suggestive of Inflammatory Latent Herpesvirus Abortive Lytic Replication in U.S. Veterans with Chronic Multi-Symptom Illnesses

    by Norman H. L. Chiu, Brandon Cox, Paula Goolkasian, Sagar Lad, Irene Mena-Paloma, James Plunkett, Robert D. Shura, Maria Eugenia Ariza, Marshall V. Williams, Sean R. Maloney

    Background: Chronic multi-symptom illness (CMI) is an idiopathic condition that can cause severe disability in U.S. Veterans. Objective: The collection of data to better characterize and assist in the development of a hypothesis that describes the pathophysiology of CMI. Design: This is an observational VA pilot study of a cohort of 40 U.S. Veterans with CMI. Methods: U.S. Veterans were initially referred to the Rehabilitation Medicine Service (RMS). From this pool of RMS patients, 36 males and four females diagnosed with CMI were selected. Data collected during this study included demographic data, medical history, psychological/cognitive information, and physical exam results. Lab tests were performed twice on the study subjects. Lab tests included serum 25(OH)D3 levels, calcium levels, and human serum IgM and IgG antibody levels to three herpetic virus dUTPase. Serum 25(OH)D3 levels were examined because active vitamin D has a role in immune system function, including the suppression of latent viruses and the modulation (attenuation) of the immune system’s inflammatory response. Herpesvirus dUTPases are proteins that are produced during viral DNA replication but are not structural components of virions. Human antibodies to dUTPase proteins were used as biomarkers for abortive lytic viral replication, a process that can stimulate an inflammatory immune process. Results: In our study subjects, the most common symptom was chronic pain (95%), the most common sign was hyperalgesia to pin prick (95%) and the most serious diagnoses were quadriparesis and neurocognitive decline in two study subjects. Conclusions: The clinical findings together with previous vitD and dUTPase serology studies suggest a possible association with low vitD levels, inflammatory elevated herpesvirus abortive lytic replication and CMI.

  • Open Access

    Clinical Characteristics and Possible Pathophysiology of Chronic Multi-Symptom Illnesses in 40 U.S. Veterans

    by Normal H.L. Chiu, Brandon Cox, Paula Goolkasian, Sagar Lad, Irene Mena Palomo, James Plunkett, Robert D. Shura, Maria Eugenia Ariza, Marshall V. Williams, Sean R. Maloney

    Background: Chronic Multi-symptom Illness (CMI) is an idiopathic condition that can cause severe disability in U.S. Veterans. Objectives: 1. The collection of data to assist in the development of a hypothesis that describes the pathophysiology of CMI and related conditions including Gulf War Illness and Chronic Fatigue Syndrome. 2. Development of a better understanding of the consequences of this syndrome on the study subjects impaired level of functioning. Design: This is an observational VA Pilot study of a cohort of 40 US Veterans with Chronic Multi-symptom illness studied between 2019 and 2025. Methods: The study population was drawn from U.S. veterans who receive medical care from the W.G. Hefner VA Health Care System in Salisbury, N.C. U.S. veterans were initially referred to the Rehabilitation Medicine Service (RMS) for various diagnoses associated with chronic or persistent pain. From this pool of RMS patients, 36 males and 4 females who were diagnosed with Chronic Multi-symptom Illness and who met the study inclusion criteria were selected to participate in the study. Data collected from this study group included: demographic, medical history, and physical symptom information, psychological and cognitive evaluation and testing data, physical exam results, and serum lab test data. Lab tests were performed twice on the study subjects. Lab tests included serum active vitamin D precursor, 25(OH)D3, levels, calcium levels, and human IgM and IgG antibody levels to dUTPase enzymes from three latent herpetic viruses, Varicella Zoster virus (VZV), Human Herpes 6 virus (HH6V), and Epstein Barr virus (EBV). Serum active vitamin D precursor levels were examined because active vitamin D has a role in immune system function including the suppression of latent viruses and the modulation (attenuation) of the immune system’s inflammatory response to microbials including latent viruses. The herpesvirus dUTPases from EBV, HH6V, and VZV are proteins/enzymes in viral DNA replication but not structural components of the mature virion. In this pilot study, antibodies against these proteins were used as biomarkers for abortive lytic replication, a process that can stimulate an inflammatory immune process. This abortive lytic inflammatory process is hypothesized to be distinct from the inflammatory response associated with full lytic viral reactivation, which results in the production of complete virions. Results: Demographic Data – 75% of study subject men and 50 % of women served in combat. Comparison of our pilot study population to the general VA population revealed differences: US Marines made up 25% of our study population versus 9.9% in the general VA population, and African American/Black study subjects made up 30% or our study population verses 15% in the VA general population. Our study subjects had high service connected, disability/ compensation ratings: 55% or 22/40 had a rating of greater than or equal to 80%, and 22.5% or 9/40 had a rating of greater than or equal to 100%. Neurological findings in study subjects included hyperalgesia to pin prick over the skin, which was present in 95% of study subjects, tinnitus (ringing in the ears) in 82% of study subjects, decreased balance on heel to toe walking which was normal in only 28.9% of study subjects with their eyes open and in only 2.7% with eyes closed. This test could not be performed in 18.4% with eyes open and in 40.5% with their eyes closed. Two study subjects developed severe quadriparesis and idiopathic neurocognitive disorders later in the study after their initial interview, physical exam, cognitive testing and blood tests were performed. Serum Lab Tests: Vitamin D, 25(OH)D3 Levels: in Trial 1 – Deficient range 11/40 (27.5%), Insufficient range 17/40 (42.5%) in Trial 2 – Deficient range 8/36 (22.2%), Insufficient range 11/36 (30.6%) Note: Only two study subjects were deficient for both seasonally adjusted 25(OH)D3 levels checked in Trials 1&2 Human IgG antibody levels to Herpesvirus dUTPase proteins: Trial 1 serum test results for human IgG serum antibody levels to herpes virus dUTPase proteins were negative for all three viruses tested in 10/40 (25%) of study subjects and positive for all three viruses examined in 7/40 (17.5%) of study subjects. Trial 2 serum test results for human IgG antibody levels to herpes virus dUTPase enzymes were negative for all three viruses tested in only 1/36 (2.8%) study subjects. Human IgG dUTPase antibodies were positive for all three viruses in 17/36 (47%) study subjects. In Trial 1 – Human VZV IgG was Pos. (elevated) for VZV dUTPase in 11/40 (12.5%) of study subjects, In Trial 2 – Human VZV IgG was Pos. (elevated) for VZV dUTPases in 23/36 (64%) of study subjects.

  • Open Access

    Epitranscriptomic Stability—Variable Extents of N1-Methyladenosine to N6-Methyladenosine Conversion Under Different Experimental Conditions

    by Frank Morales Shnaider, Hasna Kanan, Shrikant Patel, Norman H. L. Chiu

    The growing interest in epitranscriptomes has emphasized the need for accurate quantification of RNA modifications. However, the stability of RNA modifications under different experimental conditions remains poorly characterized. In this study, we use N1-methyladenosine (m1A) as a model for assessing stability. After exposing m1A ribonucleoside to various conditions that are commonly used in RNA protocols, the sample was analyzed using untargeted high-resolution mass spectrometry. Under alkaline or neutral pH, different extents of m1A were converted to N6-methyladenosine (m6A). Complete m1A-to-m6A conversion occurred at elevated temperatures. The m1A-to-m6A conversion was also dependent on the initial m1A concentration; the higher the concentration, the higher the rate of conversion. This poses a challenge to comparative studies if the initial amount of m1A in the control and sample of interest are not equal. No demethylation or depurination was detected. However, trace amount of N1-methylinosine was detected as a result of non-enzymatic deamination of m1A. Furthermore, the m1A-to-m6A conversion was consistently observed in a biological sample. To eliminate the bias that resulted from m1A-to-m6A conversion, the standard addition method was adopted. This report highlighted the challenges of having different extents of m1A-to-m6A conversion under specific experimental conditions and demonstrated a viable solution for resolving the issue.

  • Open Access

    Standard-free Quantitative Mass Spectrometry of RNA Modifications

    by Jennifer Simpson, Renata Fleming, Hongzhou Wang, Daniel Todd, Jian Teng, Bakhos Tannous, Norman Chiu

    The coupling of liquid chromatography (LC) to mass spectrometry (MS) is an accurate and proven technique for identifying different types of RNA modifications. However, due to the lack of standards and analytical biases, epitranscriptome-wide quantitative MS analysis of RNA modifications is challenging. Here, we report the development of a standard-free quantitative mass spectrometry (SqMS) method for measuring multiple RNA modifications. Starting from the extraction of total RNA to the LC-MS analysis of digested RNA, the commonly used approach is used in SqMS. To eliminate the biases that resulted from MS ionization efficiency, the SqMS method adjusts the MS signal of each ribonucleoside with a corresponding factor. Each adjustment factor is derived from measuring a serially diluted control sample, which contains a comparable set of RNA modifications as in our samples of interest. By using a post-column UV detector and the information on molar absorptivity, the ribonucleoside concentration in each diluted control sample is determined and plotted against the corresponding MS signal. The resulting dilution curve of each detectable ribonucleoside is equivalent to the standard curve, thus no ribonucleoside standard is required. After normalizing the adjusted MS signals, the accuracy of SqMS in the quantitation of multiple RNA modifications within the same sample is as good as performing the absolute quantitation. By using SqMS, the epitranscriptomic variations in glioblastoma cells were accurately differentiated.


  • Open Access

    Epitranscriptome-wide Approach for Identifying Specific Writer of RNA Modification as Knockdown Target for Resensitizing Glioblastoma Cells to Temozolomide Treatment

    by Norman Chiu, Jennifer Simpson, Frank Morales Shnaider, Renata Fleming, Bakhos Tannous

    Background: The resistance to temozolomide (TMZ) treatment remains a challenge in caring for many patients with glioblastoma (GBM) tumors. There is growing interest in unraveling the roles of epitranscriptome in cancer. Among all the known RNA modifications, 6 different modifications have been individually linked to GBM. In one of those earlier studies, Zhao and his associates reported TMZ treatment would induce higher expression of METTL3, which is one of the writers for N6-methyladenosine (m6A) modification. By combining the TMZ treatment with METTL3 silencing, the growth of TMZ-resistant xenograft was suppressed. To achieve untargeted epitranscriptome-wide analysis, our group has recently developed a mass spectrometric method that can accurately quantify each RNA modification despite its identity. Aim: In this pilot study, we aim to use an epitranscriptome-wide approach to identify a new potential target for alleviating the resistance of GBM cells to TMZ treatment. Methods and Results: In this study, patient-derived GBM cell lines that were classified as TMZ-sensitive or TMZ-resistant were chosen as in vitro models. Using our developed method, the epitranscriptomes of selected GBM cell lines were profiled. By comparing the epitranscriptomic profiles, upregulated RNA modifications were identified and correlated to the TMZ resistance. One of the most upregulated modifications is N6-methyl-N6-threonylcarbamoyladenosine (m6t6A). The association of m6t6A upregulation to TMZ resistance was confirmed by comparing the epitranscriptomes in xenografts with either primary or recurrent GBM cells. Aiming to resensitize TMZ-resistant GBM cells, the writer for m6t6A modification, known as tRNA methyltransferase O (TRMO), in selected TMZ-resistant GBM cell cultures was knocked down. The resulting cells were resensitized to lower dosages of TMZ. Conclusion: This pilot study demonstrates the use of comprehensive epitranscriptomic profiling is a feasible approach for identifying specific RNA writer of RNA modifications as a knockdown target for resensitizing GBM cells to TMZ treatment.

  • Epitranscriptomic Mass Spectrometry

    by Hongzhou Wang, Frank Morales Shnaider, Elizabeth Martin, Norman H. L. Chiu

    Every chemical group that is added to any one of the canonical ribonucleotides in a transcript would create a specific RNA modification. Currently, 170+ RNA modifications have been identified. A specific epitranscriptome refers to all the RNA modifications in a given biological system and is considered to play an important role in the regulations of cellular activities. Mass spectrometry–based methods have proven to be the most accurate way to identify RNA modifications and determine the amount of each detectable modification. Relating to the recent development of mapping specific RNA modifications within a transcriptome, the profiling of all RNA modifications can serve as a prescreening tool for mapping and provides support for analyzing the data obtained from mapping. In this chapter, the details for setting up a commonly used mass spectrometry-based method to profile all the RNA modifications in specific epitranscriptomes are described, and the possible options if available are discussed.


  • Open Access

    SARS-CoV-2 Main Protease Targets Host Selenoproteins and Glutathione Biosynthesis for Knockdown via Proteolysis, Potentially Disrupting the Thioredoxin and Glutaredoxin Redox Cycles

    by Ignacio A. Gallardo, Daniel A. Todd, Stella T. Lima, Jonathan R. Chekan, Norman H. Chiu, Ethan Will Taylor

    Associations between dietary selenium status and the clinical outcome of many viral infections, including SARS-CoV-2, are well established. Multiple independent studies have documented a significant inverse correlation between selenium status and the incidence and mortality of COVID-19. At the molecular level, SARS-CoV-2 infection has been shown to decrease the expression of certain selenoproteins, both in vitro and in COVID-19 patients. Using computational methods, our group previously identified a set of six host proteins that contain potential SARS-CoV-2 main protease (Mpro) cleavage sites. Here we show experimentally that Mpro can cleave four of the six predicted target sites, including those from three selenoproteins: thioredoxin reductase 1 (TXNRD1), selenoprotein F, and selenoprotein P, as well as the rate-limiting enzyme in glutathione synthesis, glutamate-cysteine ligase catalytic subunit (GCLC). Cleavage was assessed by incubating recombinant SARS-CoV-2 Mpro with synthetic peptides spanning the proposed cleavage sites, and analyzing the products via UPLC-MS. Furthermore, upon incubation of a recombinant Sec498Ser mutant of the full TXNRD1 protein with SARS-CoV-2 Mpro, the predicted cleavage was observed, destroying the TXNRD1 C-terminal redox center. Mechanistically, proteolytic knockdown of both TXNRD1 and GCLC is consistent with a viral strategy to inhibit DNA synthesis, conserving the pool of ribonucleotides for increased virion production. Viral infectivity could also be enhanced by GCLC knockdown, given the ability of glutathione to disrupt the structure of the viral spike protein via disulfide bond reduction. These findings shed new light on the importance of dietary factors like selenium and glutathione in COVID-19 prevention and treatment.


  • Open Access

    Abstract LB507: Towards elucidating the role of RNA modifications in cancer by improving the quantitative accuracy of mass spectrometric profiling of RNA modifications

    by Norman H. Chiu, Jennifer H. Simpson, Renata L. Fleming, Jian Teng, Bakhos A. Tannous

    The molecular structure of both coding and non-coding RNA is frequently altered by the enzymatic activity of either writer or eraser of RNA modifications. Since the RNA functions are dependent on its molecular structure, cellular activities that involve specific RNA molecule(s) can potentially be regulated by the reversible nature of RNA modifications. There are more than 140 known RNA modifications. Mass spectrometry is a proven technique for the identification of RNA modifications. However, due to the lack of ribonucleoside standards and biases in normalizing the level of RNA modifications, it remains a challenge to perform the quantitative analysis of multiple RNA modifications that may co-exist in a biological sample. Our group has recently developed a method for standard-free quantitative epitranscriptomic profiling (SqEP) that allows us using mass spectrometry to accurately determine the abundancy of each detectable RNA modification without using any ribonucleoside standards to calibrate the detection signals. Thus, the SqEP method can be used for the untargeted analysis of RNA modifications. It also allows us to directly compare the level of different RNA modifications that are detectable in an individual cell line. This is an important feature for studying the relationships between various RNA modifications. Using glioblastoma (GBM) as our model, the results from using the SqEP method to determine the level of specific RNA modifications in patient-derived GBM cell lines were shown to be more accurate than the existing methods, and complied with the gene expression data from GBM patients that are available in the Cancer Genome Atlas (TCGA) program. Citation Format: Norman H. Chiu, Jennifer H. Simpson, Renata L. Fleming, Jian Teng, Bakhos A. Tannous. Towards elucidating the role of RNA modifications in cancer by improving the quantitative accuracy of mass spectrometric profiling of RNA modifications [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr LB507.

  • Carbon Nanodots Inhibit Oxidized Low Density Lipoprotein-Induced Injury and Monocyte Adhesion to Endothelial Cells Through Scavenging Reactive Oxygen Species

    by Safeera Khan, Jessica Chavez, Xuewei Zhu, Norman H. L. Chiu, Wendi Zhang, Ziyu Yin, Jian Han, Jibin Yang, Robert Sigler, Shaomin Tian, et al.

    Oxidized low density lipoprotein (Ox-LDL) is a known biomarker of inflammation and atherosclerosis, a leading cause of death worldwide. As a new class of nanomaterials, carbon nanodots (CNDs) are widely used in bioimaging, diagnostics, and drug delivery. However, there is no current report on how these CNDs affect the cardiovascular system, particularly their potential in mediating endothelial inflammatory dysfunction. This study examined effects of CNDs on Ox-LDL-mediated endothelial dysfunction. CNDs significantly inhibited Ox-LDL-mediated adhesion of monocytes to human microvascular endothelial cells (HMEC-1), in human microvascular endothelial cells (HMEC-1). CNDs significantly inhibited Ox-LDL-mediated adhesion of monocytes to endothelial cells, which is an essential step in the development of atherosclerosis. Further, CNDs significantly inhibited OxLDL-induced expression of interleukin-8 (IL-8), a vital cytokine on monocyte adhesion to the endothelial cells. These results demonstrate CNDs possess anti-inflammatory properties. CNDs also protect cells against Ox-LDL-induced cytotoxicity. Electron paramagnetic resonance (EPR) spectroscopy studies demonstrated direct reactive oxygen species-scavenging by CNDs. This result indicates that the anti-inflammatory properties of CNDs are most likely due to their direct scavenging of reactive oxygen species. Animal studies involving mice did not show any morphological or physical changes between the CNDs and control groups. Our study provides evidence of potential of CNDs in reducing Ox-LDL-mediated inflammation and cytotoxicity in HMEC-1.